NCT06258902View on ClinicalTrials.gov

Odevixibat Pregnancy and Lactation Surveillance Program: A Study to Evaluate the Safety of Odevixibat During Pregnancy and/or Lactation

RecruitingOBSERVATIONAL
Enrollment

20

Participants

Timeline

Start Date

September 28, 2023

Primary Completion Date

September 2, 2031

Study Completion Date

September 2, 2032

Conditions
Pregnancy Related
Trial Locations (1)

28401

RECRUITING

Virtual Research Coordination Center Odevixibat (BYLVAY) Pregnancy Surveillance Program, Wilmington

Sponsors

Lead Sponsor

Ipsen
All Listed Sponsors
lead

Ipsen

INDUSTRY